Skip to content

Clinical trials

Parkinsonian Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20122
20144
20193
20202
20211
20221
20234
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Recruiting2
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adamas Pharmaceuticals, Inc.4
AbbVie3
Novartis Pharmaceuticals3
Theravance Biopharma2
University of Calgary2
Bial R&D Investments, S.A.1
BlueRock Therapeutics1
Centre hospitalier de l'Université de Montréal (CHUM)1
Ron Postuma1
Université de Sherbrooke1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease20
Parkinsonian Disorders20
Movement Disorders10
Central Nervous System Diseases7
Dyskinesias7
Neurodegenerative Diseases7
Brain Diseases6
Nervous System Diseases6
Basal Ganglia Diseases3
Dizziness2

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.